Takshashila Discussion Document - Analysis of COVID-19 Serosurveys in India

Advanced BiologyPublic Health
Written By

The Union and various state governments have conducted seroprevalence surveys at national and city/state levels to study the spread of COVID-19. We argue

  1. The disparity in estimated cases as per seroprevalence studies and actual detected cases is a result of limited testing capacity and flawed testing strategy.

  2. City level sero-surveys can help understand testing demand and should be used to tailor testing capacity at the local level.

Authors

Featured
Shambhavi Naik
Shambhavi Naik

Shambhavi Naik is the Head of Research at Takshashila and is the chairperson of the Advanced Biology programme. She has a PhD in Cancer Biology. Shambhavi’s research covers India’s policies in areas of emerging technologies, with a focus on healthcare and higher education.

Sunila Dixit
Sunila Dixit

Sunila Dixit was a Research Analyst working on Public Health issues at the Takshashila Institution. Her research included different topics related to public health, life sciences technologies and climate resilience.

Previous

Takshashila Discussion SlideDoc - A Strategy to make India a Biotech Leader by 2025
Next

IPPR Journal Article - A COVID-19 Vaccine Deployment Strategy for India